Related Experiment Video
Updated: Apr 28, 2026

Isolation and Analysis of Brain-sequestered Leukocytes from Plasmodium berghei ANKA-infected Mice
Published on: January 2, 2013
Lactate transport and receptor actions in cerebral malaria
Shelton T Mariga1, Miriam Kolko2, Albert Gjedde1
1Department of Neuroscience and Pharmacology, University of Copenhagen Copenhagen, Denmark.
Insights
Cerebral malaria (CM) may stem from brain energy metabolism issues. Malaria parasites disrupt brain lactate balance, suggesting monocarboxylate transporters (MCTs) and GPR81 as potential therapeutic targets for CM.
Area of Science:
- Neurology
- Infectious Diseases
- Biochemistry
Background:
- Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection, predominantly affecting children in tropical regions.
- High mortality rates and intractable seizures characterize CM, with current treatments proving insufficient.
- Understanding the underlying pathogenesis of CM is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the role of cerebral energy metabolic defects in the pathogenesis of cerebral malaria.
- To explore monocarboxylate transporters (MCTs) and the lactate receptor GPR81 as potential therapeutic targets in CM.
Main Methods:
- Review of existing literature on malaria parasite metabolism and brain energy homeostasis.
- Analysis of the role of lactate production by malaria parasites.
- Examination of the function of monocarboxylate transporters (MCTs) in lactate transport.
- Investigation of the recently discovered lactate receptor GPR81.
Main Results:
- Malaria parasites significantly consume glucose, leading to increased lactate production.
- Monocarboxylate transporters (MCTs) facilitate lactate transfer, influencing brain metabolic signaling.
- High parasite-derived lactate may compromise the blood-brain barrier and disrupt brain lactate homeostasis.
- Lactate binding to GPR81 on brain cells and vasculature inhibits adenylyl cyclase.
Conclusions:
- Cerebral energy metabolic defects, particularly related to lactate, are implicated in CM pathogenesis.
- Monocarboxylate transporters (MCTs) and the lactate receptor GPR81 represent promising novel therapeutic targets for managing cerebral malaria.
Abstract:
Cerebral malaria (CM), caused by Plasmodium falciparum infection, is a prevalent neurological disorder in the tropics. Most of the patients are children, typically with intractable seizures and high mortality. Current treatment is unsatisfactory. Understanding the pathogenesis of CM is required in order to identify therapeutic targets. Here, we argue that cerebral energy metabolic defects are probable etiological factors in CM pathogenesis, because malaria parasites consume large amounts of glucose metabolized mostly to lactate. Monocarboxylate transporters (MCTs) mediate facilitated transfer, which serves to equalize lactate concentrations across cell membranes in the direction of the concentration gradient. The equalizing action of MCTs is the basis for lactate's role as a volume transmitter of metabolic signals in the brain. Lactate binds to the lactate receptor GPR81, recently discovered on brain cells and cerebral blood vessels, causing inhibition of adenylyl cyclase. High levels of lactate delivered by the parasite at the vascular endothelium may damage the blood-brain barrier, disrupt lactate homeostasis in the brain, and imply MCTs and the lactate receptor as novel therapeutic targets in CM.
More Related Videos
09:04In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging
Published on: June 8, 2017
10:09Selection of Plasmodium falciparum Parasites for Cytoadhesion to Human Brain Endothelial Cells
Published on: January 3, 2012
Related Concept Videos
Transcellular Transport of Solutes
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Secondary Active Transport
Secondary Active Transport